Ankilozan spondilit hastalarının diürnal kan basıncı değişkenliğinin normal popülasyonla karşılaştırılması
Yıl 2019,
Cilt: 29 Sayı: 2, 60 - 64, 01.03.2019
Özge Turgay Yıldırım
Emel Gönüllü
Fatih Aydın
Evrin Dağtekin
Ayşe Hüseyinoğlu Aydın
Ercan Akşit
Öz
Amaç: Ankilozan spondilit AS hastalarında kardiyak tutulum %10-30 oranında görülür. Kronik inflamasyon, ankilozan spondilitte olduğu gibi kardiyovasküler hastalıklar, hipertansiyon ve diürnal kan basıncı değişkenliğinin patofizyolojinde rol almaktadır. Azalmış kan basıncı değişkenliği kardiyovasküler olaylar için yüksek risk göstergesidir. Bu çalışma ile amacımız AS hastalarında diürnal kan basıncı değişikliğinin normal popülasyonla karşılaştırılmasıdır. Gereç ve Yöntem: Bu çalışma için 25 AS hastası ve 32 kontrol alınmıştır. Hipertansif hastalar, hipertansif tedavi almakta olan veya ambulatuar kan basıncı monitorizasyonu ABPM sonuçlarına göre gündüz kan basıncı ortalaması SKB/DKB>135/85 mmHg ve/veya gece kan basıncı ortalaması SKB/DKB>120/70 mmHg olması şeklinde tanımlanmıştır. Dipper paterni gece kan basıncı ortalamasının gündüze oranla %10 ve daha fazla düşmesi olarak tanımlandı. Bulgular: Araştırmanın yaş ortalaması 42.5±12.1 yıldır ve % 63.2'si erkektir. Kontrol grubu ve AS grupları arasında temel demografik özellikler açısından anlamlı fark yoktur. ABPM sonuçlarına göre; AS grubunun %36’sı n=9 ve kontrol grubunun %46.9’u n=15 hipertansif olarak belirlenmiştir ve gruplar arasında istatistiksel fark saptanmamıştır p=0.290 . AS hastaları ve kontrol grubu arasında ortalama, gündüz ve gece; sistolik ve diyastolik kan basıncı sonuçları açısından anlamlı fark saptanmamıştır p>0.05 . AS hastalarının %76.0’ında n=19 ve kontrol grubunun %71.8’inde n=23 non-dipper patern saptanmıştır. Bu oranlar arasındaki fark istatistiksel açıdan anlamlı değildir p=0.949 . Gece gündüz arası sistolik kan basıncı değişkenlikleri açısından gruplar arasında fark saptanmamıştır p=0.772 .Sonuç: Çalışmamızın sonuçlarına göre non-dipper paterni ve diürnal kan basıncı değişimi AS hastalarında ve kontrol grubunda benzerdir. Hipertansif ve normotansif hastalar alt grup analizinde değerlendirildiğinde de gruplar arasında non-dipper hastaları ve diürnal kan basıncı değişkenliği açısından fark saptanmamıştır
Kaynakça
- Turesson C, Jacobsson LT, Matteson EL. Cardiovascular co-morbidity in rheumatic diseases. Vasc Health Risk Ma- nag 2008; 4: 605–14.
- Yang DH. Ankylosing spondylitis and cardiac abnorımali- ties. J Cardiovasc Ultrasound 2012; 20: 23-4.
- Brunner F, Kunz A, Weber U, Kissling R. Ankylosing spondylitis and heart abnormalities: do cardiac conduction disorders, valve regurgitation and diastolic dysfunction oc- cur more often in male patients with diagnosed ankylosing spondylitis for over 15 years than in the normal population? Clin Rheumatol 2006; 25: 24-9.
- Roldan CA. Valvular and coronary heart disease in syste- mic inflammatory diseases: Systemic Disorders in heart di- sease. Heart 2008; 94: 1089-101.
- O'Neill TW, Bresnihan B. The heart in ankylosing spondyli- tis. Ann Rheum Dis 1992; 51: 705–6.
- Peters MJ, Symmons DP, McCarey D, Dijkmans BA, Nicola P, Kvien TK, et al. EULAR evidence-based recommendati- ons for cardiovascular risk manageıment in patients with rheumatoid arthritis and other forms of inflammatory arth- ritis. Ann Rheum Dis 2010; 69: 325-31.
- El Maghraoui A. Extra-articular manifestations of ankylo- sing spondylitis: prevalence, characteristics and therapeutic implications. Eur J Intern Med 2011; 22: 554-60.
- Savoia C, Schiffrin EL. Inflammation in hypertension. Curr Opin NephrolHypertens 2006; 15: 152-8.
- Känel R, Jain S, Mills PJ, Nelesen RA, Adler KA, Hong S et al. Relation of nocturnal blood pressure dipping to cellular adhesion, inflammation and hemostasis. J Hypertens 2004; 22: 2087-93.
- Turgay Yildirim O, Gonullu E, Aydin F, Aksit E, Huseyi- noglu Aydin A, Dagtekin E. Nocturnal blood pressure dip- ping is similar in rheumatoid arthritis patients as compared to a normal population. Z Rheumatol 2018 Apr 12. doi: 10.1007/s00393-018-0451-4.
- Karakulak UN, Sahiner L, Maharjan N, Okutucu S, Evra- nos B, Aladag E, et al. Evaluation of the ambulatory arterial stiffness index in patients with rheumatoid arthritis. Blood Press Monit 2015; 20: 254-9.
- Mancia G, Parati G. Ambulatory blood pressure monito- ring and organ damage. Hypertension. 2000; 36: 894-900.
- Salles GF, Reboldi G, Fagard RH, Cardoso CR, Pierdomeni- co SD, Verdecchia P et al. Prognostic effect of the nocturnal blood pressure fall in hypertensive patients: The ambulatory blood pressure collaboration in patients with hypertension (ABC-H) meta-analysis. Hypertension 2016; 67: 693-700.
- Berg IJ, van der Heijde D, Dagfinrud H, et al. Disease ac- tivity in ankylosing spondylitis and associations to mar- kers of vascular pathology and traditional cardiovascular disease risk factors: a cross-sectional study. J Rheumatol 2015;42:645-53.
- Vinker Shuster M, Gendelman O, Tiosano S, Comaneshter D, Cohen AD, Amital H. Ischemic heart disease and anky- losing spondylitis-assessing the role of inflammation. Clin Rheumatol 2018; 37: 1053-8.
- Han C, Robinson DW Jr, Hackett MV, Paramore LC, Frae- man KH, Bala MV. Cardiovascular disease and risk factors in patients with rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis. J Rheumatol 2006;33:2167-72.
- Alves MG, Espirito-Santo J, Queiroz MV, Madeira H, Ma- cieira-Coelho E. Cardiac alterations in ankylosing spondy- litis. Angiology 1988;39:567-71.
- Peters MJ, van der Horst-Bruinsma IE, Dijkmans BA, Nurmohamed MT. Cardiovascular risk profile of pa- tients with spondylarthropathies, particularly ankylosing spondylitis and psoriatic arthritis. Semin Arthritis Rheum 2004;34:585-92.
- van Eijk IC, Peters MJ, Serné EH, van der Horst-Bruinsma IE, Dijkmans BA, Smulders YM, et al. Microvascular fun- ction is impaired in ankylosing spondylitis and improves after tumour necrosis factor alpha blockade.Ann Rheum Dis 2009;68:362-6.
Yıl 2019,
Cilt: 29 Sayı: 2, 60 - 64, 01.03.2019
Özge Turgay Yıldırım
Emel Gönüllü
Fatih Aydın
Evrin Dağtekin
Ayşe Hüseyinoğlu Aydın
Ercan Akşit
Öz
Objective: Cardiac involvement is seen in 10-30% of patients with ankylosing spondylitis AS . Chronic inflammation plays major rol for patophysiology of AS as well as cardiovascular disease,hypertension anddiurnal blood pressure variability DBPV . Decreased DBPVis a marker of high risk for cardiovascular events. Our aim is to compare DBPV in AS patients with normal population.Material and Methods: A total of 25 AS patients and 32 controls enrolled for this study. Hypertensive patients were defined according to results of ambulatory blood pressure monitorization ABPM results or patients under hypertensive treatment. Dipper status was defined as %10 or more systolic blood pressure BP fall compared to daytime values.Results: The mean age of study population was 42.5±12.1 years and 63.2% were male. There was no significant difference between control group and AS group in terms of basic demographics. According to ABPM results; 36% n=9 of the AS group and 46.9% n=15 of the control group were hypertensive and there was no statistical difference between groups p=0.290 . Mean, daytime and nighttime sistolic and diastolic BP were similar p>0.05 . Non-dipper pattern was found in 76.0% n=19 of AS patients and 71.8% n=23 of control group. The difference between these ratios was not statistically significant p=0.949 . There was no difference between the groups in terms of DBPV p=0.772 .Conclusion: In conclusion, non-dipper pattern and DBPV were similar in AS patients and control group. When assessed by subgroup analysis of hypertensive and normotensive patients, there was no difference between the groups in terms of non-dipper patients and DBPV
Kaynakça
- Turesson C, Jacobsson LT, Matteson EL. Cardiovascular co-morbidity in rheumatic diseases. Vasc Health Risk Ma- nag 2008; 4: 605–14.
- Yang DH. Ankylosing spondylitis and cardiac abnorımali- ties. J Cardiovasc Ultrasound 2012; 20: 23-4.
- Brunner F, Kunz A, Weber U, Kissling R. Ankylosing spondylitis and heart abnormalities: do cardiac conduction disorders, valve regurgitation and diastolic dysfunction oc- cur more often in male patients with diagnosed ankylosing spondylitis for over 15 years than in the normal population? Clin Rheumatol 2006; 25: 24-9.
- Roldan CA. Valvular and coronary heart disease in syste- mic inflammatory diseases: Systemic Disorders in heart di- sease. Heart 2008; 94: 1089-101.
- O'Neill TW, Bresnihan B. The heart in ankylosing spondyli- tis. Ann Rheum Dis 1992; 51: 705–6.
- Peters MJ, Symmons DP, McCarey D, Dijkmans BA, Nicola P, Kvien TK, et al. EULAR evidence-based recommendati- ons for cardiovascular risk manageıment in patients with rheumatoid arthritis and other forms of inflammatory arth- ritis. Ann Rheum Dis 2010; 69: 325-31.
- El Maghraoui A. Extra-articular manifestations of ankylo- sing spondylitis: prevalence, characteristics and therapeutic implications. Eur J Intern Med 2011; 22: 554-60.
- Savoia C, Schiffrin EL. Inflammation in hypertension. Curr Opin NephrolHypertens 2006; 15: 152-8.
- Känel R, Jain S, Mills PJ, Nelesen RA, Adler KA, Hong S et al. Relation of nocturnal blood pressure dipping to cellular adhesion, inflammation and hemostasis. J Hypertens 2004; 22: 2087-93.
- Turgay Yildirim O, Gonullu E, Aydin F, Aksit E, Huseyi- noglu Aydin A, Dagtekin E. Nocturnal blood pressure dip- ping is similar in rheumatoid arthritis patients as compared to a normal population. Z Rheumatol 2018 Apr 12. doi: 10.1007/s00393-018-0451-4.
- Karakulak UN, Sahiner L, Maharjan N, Okutucu S, Evra- nos B, Aladag E, et al. Evaluation of the ambulatory arterial stiffness index in patients with rheumatoid arthritis. Blood Press Monit 2015; 20: 254-9.
- Mancia G, Parati G. Ambulatory blood pressure monito- ring and organ damage. Hypertension. 2000; 36: 894-900.
- Salles GF, Reboldi G, Fagard RH, Cardoso CR, Pierdomeni- co SD, Verdecchia P et al. Prognostic effect of the nocturnal blood pressure fall in hypertensive patients: The ambulatory blood pressure collaboration in patients with hypertension (ABC-H) meta-analysis. Hypertension 2016; 67: 693-700.
- Berg IJ, van der Heijde D, Dagfinrud H, et al. Disease ac- tivity in ankylosing spondylitis and associations to mar- kers of vascular pathology and traditional cardiovascular disease risk factors: a cross-sectional study. J Rheumatol 2015;42:645-53.
- Vinker Shuster M, Gendelman O, Tiosano S, Comaneshter D, Cohen AD, Amital H. Ischemic heart disease and anky- losing spondylitis-assessing the role of inflammation. Clin Rheumatol 2018; 37: 1053-8.
- Han C, Robinson DW Jr, Hackett MV, Paramore LC, Frae- man KH, Bala MV. Cardiovascular disease and risk factors in patients with rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis. J Rheumatol 2006;33:2167-72.
- Alves MG, Espirito-Santo J, Queiroz MV, Madeira H, Ma- cieira-Coelho E. Cardiac alterations in ankylosing spondy- litis. Angiology 1988;39:567-71.
- Peters MJ, van der Horst-Bruinsma IE, Dijkmans BA, Nurmohamed MT. Cardiovascular risk profile of pa- tients with spondylarthropathies, particularly ankylosing spondylitis and psoriatic arthritis. Semin Arthritis Rheum 2004;34:585-92.
- van Eijk IC, Peters MJ, Serné EH, van der Horst-Bruinsma IE, Dijkmans BA, Smulders YM, et al. Microvascular fun- ction is impaired in ankylosing spondylitis and improves after tumour necrosis factor alpha blockade.Ann Rheum Dis 2009;68:362-6.